An advisory board to the FDA said that the agency ignored evidence that suggested BPA in baby bottles and formula cans could be damaging to children.
“EFSA is obviously aware of the developments in the US and is following the situation closely. However, no revision of the existing EFSA opinions on BPA is envisaged at the moment,” a spokesperson for the regulator told FoodProductionDaily.com.
The Science Board, which is made up of independent experts and advises the FDA commissioner on scientific and technical matters, voted unanimously last week to approve the recommendations made by its subcommittee on BPA.
The subcommittee's review concluded that the margins of safety in the FDA draft assessment on BPA in regard to the risks of infant exposure to the chemical were “inadequate.”